Open AccessAnticholinergic Medication Burden in Parkinson’s Disease Outpatients
Author(s) -
Huma Nawaz,
Lana Sargent,
Helengrace Quilon,
Leslie Cloud,
Claudia M. Testa,
Jon D. Snider,
Sarah K. Lageman,
Mark S. Baron,
Brian D. Berman,
Kristin M. Zimmerman,
Elvin T. Price,
Nitai D. Mukhopadhyay,
Matthew J. Barrett
Publication year - 2021
Publication title -
journal of parkinson s disease
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.747
H-Index - 45
eISSN - 1877-718X
pISSN - 1877-7171
DOI - 10.3233/jpd-212769
Subject(s) - anticholinergic , medicine , anticholinergic agents , antipsychotic , psychiatry , schizophrenia (object oriented programming)
Individuals with Parkinson's disease (PD) may be especially vulnerable to future cognitive decline from anticholinergic medications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom